{ "uri": "https://www.find-tender.service.gov.uk/api/1.0/ocdsRecordPackages/ocds-h6vhtk-0782d2", "publisher": { "name": "Cabinet Office", "scheme": "GB-GOR", "uid": "D2", "uri": "https://www.gov.uk/government/organisations/cabinet-office" }, "publishedDate": "2026-10-07T14:21:57+01:00", "license": "http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "publicationPolicy": "https://www.gov.uk/government/publications/open-contracting", "version": "1.1", "extensions": [ "https://standard.open-contracting.org/profiles/eu/latest/en/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json", "https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json", "https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json" ], "packages": [ "https://www.find-tender.service.gov.uk/api/1.0/ocdsRecordPackages/ocds-h6vhtk-0782d2" ], "records": [ { "ocid": "ocds-h6vhtk-0782d2", "releases": [ { "ocid": "ocds-h6vhtk-0782d2", "id": "094795-2026", "tag": [ "planning" ], "date": "2026-10-07T14:21:57+01:00", "initiationType": "tender", "parties": [ { "name": "NHS Blood and Transplant", "id": "GB-PPON-PDBY-6395-VWBP", "identifier": { "scheme": "GB-PPON", "id": "PDBY-6395-VWBP" }, "address": { "streetAddress": "500 North Bristol Park", "locality": "Bristol", "postalCode": "BS34 7QH", "country": "GB", "countryName": "United Kingdom", "region": "UKK12" }, "contactPoint": { "name": "Sahithi Bandi", "email": "sahithi.bandi@nhsbt.nhs.uk", "telephone": "07385149017" }, "roles": [ "buyer" ], "details": { "url": "https://www.nhsbt.nhs.uk/", "classifications": [ { "scheme": "UK_CA_TYPE", "id": "publicAuthorityCentralGovernment", "description": "Public authority - central government" } ] } } ], "buyer": { "id": "GB-PPON-PDBY-6395-VWBP", "name": "NHS Blood and Transplant" }, "planning": { "milestones": [ { "id": "engagement", "type": "engagement", "description": "NHS Blood and Transplant, NHSBT, is undertaking preliminary market engagement in connection with a proposed procurement for the provision of Qualified Person, QP, services for Investigational Medicinal Products, IMPs.\nNHSBT is seeking to understand the capability, capacity and interest available within the market to provide suitably qualified and experienced QP support for its active portfolio of IMP manufacturing projects.\nThe proposed service may include:\nReviewing and providing regulatory and quality input into selected regulatory submissions, as requested by NHSBT.\nAdvising on applicable regulatory, Good Manufacturing Practice, GMP, and quality-compliance requirements for biological and Advanced Therapy Medicinal Product, ATMP, manufacturing projects.\nProviding regulatory, GMP and quality input into the design and development of selected manufacturing processes and facilities.\nReviewing assigned batches and, where satisfied that all applicable legal, regulatory, GMP, Clinical Trial Authorisation, Product Specification File and NHSBT quality-system requirements have been met, certifying the batches for use in approved clinical trials.\nProviding advice and guidance relating to the manufacture, certification and release of IMP batches.\nSupporting NHSBT with the interpretation and application of relevant regulatory and quality requirements.\nMentoring selected NHSBT staff through the process of obtaining Qualified Person registration.\nEach Qualified Person proposed by the supplier will be expected to hold and maintain the qualifications, professional eligibility and regulatory status required to act as a Qualified Person for Investigational Medicinal Products in the United Kingdom.\nThe supplier may be required to provide supporting evidence of the proposed Qualified Person’s qualifications, professional eligibility, regulatory status and relevant experience.\nProposed personnel should have recent and demonstrable experience of:\nacting as a named Qualified Person on a UK Manufacturing and Import Authorisation for Investigational Medicinal Products, MIA(IMP);\nreviewing and certifying IMP batches;\napplying UK regulatory, GMP and quality requirements;\nsupporting biological and biotechnology medicinal-product manufacturing;\nsupporting cell therapy and gene therapy medicinal products; and\nworking with complex IMP manufacturing projects and associated quality systems.\nThe current anticipated level of support is approximately 24 to 48 days per year. NHSBT currently anticipates that at least 50% of the required support will be delivered on NHSBT premises, with the remaining support delivered remotely by agreement.\nThe final scope, service-delivery arrangements, volume of activity and contract requirements may be refined following the preliminary market engagement exercise.\nThe current contract ends on 30 June 2027. NHSBT intends to have the replacement contractual arrangement in place by 31 March 2027 to support an appropriate transition period.", "dueDate": "2026-11-06T23:59:59Z", "status": "scheduled" } ], "documents": [ { "id": "094795-2026", "documentType": "marketEngagementNotice", "noticeType": "UK2", "description": "Preliminary market engagement notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/094795-2026", "datePublished": "2026-10-07T14:21:57+01:00", "format": "text/html" } ] }, "tender": { "id": "C475831", "legalBasis": { "id": "2023/54", "scheme": "UKPGA", "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents" }, "title": "Qualified Person Service for Investigational Medicinal Products (IMP)", "description": "NHS Blood and Transplant is seeking to appoint a suitably qualified and experienced supplier to provide Qualified Person services in support of its portfolio of Investigational Medicinal Product manufacturing projects.\nThe proposed service may include:\nreviewing and providing regulatory and quality input into selected regulatory submissions;\nadvising on applicable regulatory, Good Manufacturing Practice and quality-compliance requirements for biological and Advanced Therapy Medicinal Product manufacturing projects;\nproviding regulatory, GMP and quality input into the design and development of selected manufacturing processes and facilities;\nreviewing assigned batches and, where all applicable legal, regulatory, GMP, Clinical Trial Authorisation, Product Specification File and NHSBT quality-system requirements have been met, certifying batches for use in approved clinical trials;\nmentoring selected NHSBT staff undertaking the process of obtaining Qualified Person registration; and\nproviding associated professional, regulatory and quality advice as required.\nEach Qualified Person proposed by the supplier will be expected to hold and maintain the qualifications, professional eligibility and regulatory status required to act as a Qualified Person for Investigational Medicinal Products in the UK.\nProposed personnel should have recent and demonstrable experience of acting as a named Qualified Person on a UK Manufacturing and Import Authorisation for Investigational Medicinal Products, MIA(IMP), and of certifying IMP batches. Experience relating to biological, biotechnology, cell therapy and gene therapy medicinal products may also be required.\nThe current anticipated level of support is approximately 24 to 48 days per year, with at least 50% of the support delivered on NHSBT premises and the remaining support delivered remotely, subject to agreement.\nThe scope and requirements described in this notice are indicative and may be refined following preliminary market engagement.", "items": [ { "id": "1", "additionalClassifications": [ { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "relatedLot": "1" } ], "value": { "amountGross": 259200, "amount": 216000, "currency": "GBP" }, "mainProcurementCategory": "services", "aboveThreshold": true, "lots": [ { "id": "1", "suitability": { "sme": true, "vcse": true }, "contractPeriod": { "startDate": "2027-03-31T00:00:00+01:00", "endDate": "2030-03-31T23:59:59+01:00", "maxExtentDate": "2032-03-31T23:59:59+01:00" }, "hasRenewal": true, "status": "planning" } ], "communication": { "futureNoticeDate": "2026-12-04T23:59:59Z" }, "status": "planning" }, "language": "en", "extensions": [ "https://standard.open-contracting.org/profiles/eu/latest/en/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json", "https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json", "https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json" ] } ], "compiledRelease": { "tag": [ "compiled" ], "id": "ocds-h6vhtk-0782d2-2026-10-07T14:21:57+01:00", "date": "2026-10-07T14:21:57+01:00", "ocid": "ocds-h6vhtk-0782d2", "initiationType": "tender", "parties": [ { "id": "GB-PPON-PDBY-6395-VWBP", "name": "NHS Blood and Transplant", "identifier": { "scheme": "GB-PPON", "id": "PDBY-6395-VWBP" }, "address": { "streetAddress": "500 North Bristol Park", "locality": "Bristol", "postalCode": "BS34 7QH", "country": "GB", "countryName": "United Kingdom", "region": "UKK12" }, "contactPoint": { "name": "Sahithi Bandi", "email": "sahithi.bandi@nhsbt.nhs.uk", "telephone": "07385149017" }, "roles": [ "buyer" ], "details": { "url": "https://www.nhsbt.nhs.uk/", "classifications": [ { "scheme": "UK_CA_TYPE", "id": "publicAuthorityCentralGovernment", "description": "Public authority - central government" } ] } } ], "buyer": { "id": "GB-PPON-PDBY-6395-VWBP", "name": "NHS Blood and Transplant" }, "planning": { "milestones": [ { "id": "engagement", "type": "engagement", "description": "NHS Blood and Transplant, NHSBT, is undertaking preliminary market engagement in connection with a proposed procurement for the provision of Qualified Person, QP, services for Investigational Medicinal Products, IMPs.\nNHSBT is seeking to understand the capability, capacity and interest available within the market to provide suitably qualified and experienced QP support for its active portfolio of IMP manufacturing projects.\nThe proposed service may include:\nReviewing and providing regulatory and quality input into selected regulatory submissions, as requested by NHSBT.\nAdvising on applicable regulatory, Good Manufacturing Practice, GMP, and quality-compliance requirements for biological and Advanced Therapy Medicinal Product, ATMP, manufacturing projects.\nProviding regulatory, GMP and quality input into the design and development of selected manufacturing processes and facilities.\nReviewing assigned batches and, where satisfied that all applicable legal, regulatory, GMP, Clinical Trial Authorisation, Product Specification File and NHSBT quality-system requirements have been met, certifying the batches for use in approved clinical trials.\nProviding advice and guidance relating to the manufacture, certification and release of IMP batches.\nSupporting NHSBT with the interpretation and application of relevant regulatory and quality requirements.\nMentoring selected NHSBT staff through the process of obtaining Qualified Person registration.\nEach Qualified Person proposed by the supplier will be expected to hold and maintain the qualifications, professional eligibility and regulatory status required to act as a Qualified Person for Investigational Medicinal Products in the United Kingdom.\nThe supplier may be required to provide supporting evidence of the proposed Qualified Person’s qualifications, professional eligibility, regulatory status and relevant experience.\nProposed personnel should have recent and demonstrable experience of:\nacting as a named Qualified Person on a UK Manufacturing and Import Authorisation for Investigational Medicinal Products, MIA(IMP);\nreviewing and certifying IMP batches;\napplying UK regulatory, GMP and quality requirements;\nsupporting biological and biotechnology medicinal-product manufacturing;\nsupporting cell therapy and gene therapy medicinal products; and\nworking with complex IMP manufacturing projects and associated quality systems.\nThe current anticipated level of support is approximately 24 to 48 days per year. NHSBT currently anticipates that at least 50% of the required support will be delivered on NHSBT premises, with the remaining support delivered remotely by agreement.\nThe final scope, service-delivery arrangements, volume of activity and contract requirements may be refined following the preliminary market engagement exercise.\nThe current contract ends on 30 June 2027. NHSBT intends to have the replacement contractual arrangement in place by 31 March 2027 to support an appropriate transition period.", "dueDate": "2026-11-06T23:59:59Z", "status": "scheduled" } ], "documents": [ { "id": "094795-2026", "documentType": "marketEngagementNotice", "noticeType": "UK2", "description": "Preliminary market engagement notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/094795-2026", "datePublished": "2026-10-07T14:21:57+01:00", "format": "text/html" } ] }, "tender": { "id": "C475831", "legalBasis": { "id": "2023/54", "scheme": "UKPGA", "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents" }, "title": "Qualified Person Service for Investigational Medicinal Products (IMP)", "description": "NHS Blood and Transplant is seeking to appoint a suitably qualified and experienced supplier to provide Qualified Person services in support of its portfolio of Investigational Medicinal Product manufacturing projects.\nThe proposed service may include:\nreviewing and providing regulatory and quality input into selected regulatory submissions;\nadvising on applicable regulatory, Good Manufacturing Practice and quality-compliance requirements for biological and Advanced Therapy Medicinal Product manufacturing projects;\nproviding regulatory, GMP and quality input into the design and development of selected manufacturing processes and facilities;\nreviewing assigned batches and, where all applicable legal, regulatory, GMP, Clinical Trial Authorisation, Product Specification File and NHSBT quality-system requirements have been met, certifying batches for use in approved clinical trials;\nmentoring selected NHSBT staff undertaking the process of obtaining Qualified Person registration; and\nproviding associated professional, regulatory and quality advice as required.\nEach Qualified Person proposed by the supplier will be expected to hold and maintain the qualifications, professional eligibility and regulatory status required to act as a Qualified Person for Investigational Medicinal Products in the UK.\nProposed personnel should have recent and demonstrable experience of acting as a named Qualified Person on a UK Manufacturing and Import Authorisation for Investigational Medicinal Products, MIA(IMP), and of certifying IMP batches. Experience relating to biological, biotechnology, cell therapy and gene therapy medicinal products may also be required.\nThe current anticipated level of support is approximately 24 to 48 days per year, with at least 50% of the support delivered on NHSBT premises and the remaining support delivered remotely, subject to agreement.\nThe scope and requirements described in this notice are indicative and may be refined following preliminary market engagement.", "items": [ { "id": "1", "additionalClassifications": [ { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ], "relatedLot": "1" } ], "value": { "amountGross": 259200, "amount": 216000, "currency": "GBP" }, "mainProcurementCategory": "services", "aboveThreshold": true, "lots": [ { "id": "1", "suitability": { "sme": true, "vcse": true }, "contractPeriod": { "startDate": "2027-03-31T00:00:00+01:00", "endDate": "2030-03-31T23:59:59+01:00", "maxExtentDate": "2032-03-31T23:59:59+01:00" }, "hasRenewal": true, "status": "planning" } ], "communication": { "futureNoticeDate": "2026-12-04T23:59:59Z" }, "status": "planning" }, "language": "en", "extensions": [ "https://standard.open-contracting.org/profiles/eu/latest/en/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json", "https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json", "https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json" ] }, "versionedRelease": { "ocid": "ocds-h6vhtk-0782d2", "initiationType": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "tender" } ], "parties": [ { "id": "GB-PPON-PDBY-6395-VWBP", "name": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "NHS Blood and Transplant" } ], "identifier": { "scheme": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "GB-PPON" } ], "id": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "PDBY-6395-VWBP" } ] }, "address": { "streetAddress": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "500 North Bristol Park" } ], "locality": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "Bristol" } ], "postalCode": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "BS34 7QH" } ], "country": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "GB" } ], "countryName": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "United Kingdom" } ], "region": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "UKK12" } ] }, "contactPoint": { "name": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "Sahithi Bandi" } ], "email": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "sahithi.bandi@nhsbt.nhs.uk" } ], "telephone": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "07385149017" } ] }, "roles": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": [ "buyer" ] } ], "details": { "url": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "https://www.nhsbt.nhs.uk/" } ], "classifications": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": [ { "scheme": "UK_CA_TYPE", "id": "publicAuthorityCentralGovernment", "description": "Public authority - central government" } ] } ] } } ], "buyer": { "id": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "GB-PPON-PDBY-6395-VWBP" } ], "name": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "NHS Blood and Transplant" } ] }, "planning": { "milestones": [ { "id": "engagement", "type": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "engagement" } ], "description": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "NHS Blood and Transplant, NHSBT, is undertaking preliminary market engagement in connection with a proposed procurement for the provision of Qualified Person, QP, services for Investigational Medicinal Products, IMPs.\nNHSBT is seeking to understand the capability, capacity and interest available within the market to provide suitably qualified and experienced QP support for its active portfolio of IMP manufacturing projects.\nThe proposed service may include:\nReviewing and providing regulatory and quality input into selected regulatory submissions, as requested by NHSBT.\nAdvising on applicable regulatory, Good Manufacturing Practice, GMP, and quality-compliance requirements for biological and Advanced Therapy Medicinal Product, ATMP, manufacturing projects.\nProviding regulatory, GMP and quality input into the design and development of selected manufacturing processes and facilities.\nReviewing assigned batches and, where satisfied that all applicable legal, regulatory, GMP, Clinical Trial Authorisation, Product Specification File and NHSBT quality-system requirements have been met, certifying the batches for use in approved clinical trials.\nProviding advice and guidance relating to the manufacture, certification and release of IMP batches.\nSupporting NHSBT with the interpretation and application of relevant regulatory and quality requirements.\nMentoring selected NHSBT staff through the process of obtaining Qualified Person registration.\nEach Qualified Person proposed by the supplier will be expected to hold and maintain the qualifications, professional eligibility and regulatory status required to act as a Qualified Person for Investigational Medicinal Products in the United Kingdom.\nThe supplier may be required to provide supporting evidence of the proposed Qualified Person’s qualifications, professional eligibility, regulatory status and relevant experience.\nProposed personnel should have recent and demonstrable experience of:\nacting as a named Qualified Person on a UK Manufacturing and Import Authorisation for Investigational Medicinal Products, MIA(IMP);\nreviewing and certifying IMP batches;\napplying UK regulatory, GMP and quality requirements;\nsupporting biological and biotechnology medicinal-product manufacturing;\nsupporting cell therapy and gene therapy medicinal products; and\nworking with complex IMP manufacturing projects and associated quality systems.\nThe current anticipated level of support is approximately 24 to 48 days per year. NHSBT currently anticipates that at least 50% of the required support will be delivered on NHSBT premises, with the remaining support delivered remotely by agreement.\nThe final scope, service-delivery arrangements, volume of activity and contract requirements may be refined following the preliminary market engagement exercise.\nThe current contract ends on 30 June 2027. NHSBT intends to have the replacement contractual arrangement in place by 31 March 2027 to support an appropriate transition period." } ], "dueDate": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "2026-11-06T23:59:59Z" } ], "status": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "scheduled" } ] } ], "documents": [ { "id": "094795-2026", "documentType": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "marketEngagementNotice" } ], "noticeType": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "UK2" } ], "description": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "Preliminary market engagement notice on Find a Tender" } ], "url": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "https://www.find-tender.service.gov.uk/Notice/094795-2026" } ], "datePublished": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "2026-10-07T14:21:57+01:00" } ], "format": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "text/html" } ] } ] }, "tender": { "id": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "C475831" } ], "legalBasis": { "id": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "2023/54" } ], "scheme": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "UKPGA" } ], "uri": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "https://www.legislation.gov.uk/ukpga/2023/54/contents" } ] }, "title": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "Qualified Person Service for Investigational Medicinal Products (IMP)" } ], "description": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "NHS Blood and Transplant is seeking to appoint a suitably qualified and experienced supplier to provide Qualified Person services in support of its portfolio of Investigational Medicinal Product manufacturing projects.\nThe proposed service may include:\nreviewing and providing regulatory and quality input into selected regulatory submissions;\nadvising on applicable regulatory, Good Manufacturing Practice and quality-compliance requirements for biological and Advanced Therapy Medicinal Product manufacturing projects;\nproviding regulatory, GMP and quality input into the design and development of selected manufacturing processes and facilities;\nreviewing assigned batches and, where all applicable legal, regulatory, GMP, Clinical Trial Authorisation, Product Specification File and NHSBT quality-system requirements have been met, certifying batches for use in approved clinical trials;\nmentoring selected NHSBT staff undertaking the process of obtaining Qualified Person registration; and\nproviding associated professional, regulatory and quality advice as required.\nEach Qualified Person proposed by the supplier will be expected to hold and maintain the qualifications, professional eligibility and regulatory status required to act as a Qualified Person for Investigational Medicinal Products in the UK.\nProposed personnel should have recent and demonstrable experience of acting as a named Qualified Person on a UK Manufacturing and Import Authorisation for Investigational Medicinal Products, MIA(IMP), and of certifying IMP batches. Experience relating to biological, biotechnology, cell therapy and gene therapy medicinal products may also be required.\nThe current anticipated level of support is approximately 24 to 48 days per year, with at least 50% of the support delivered on NHSBT premises and the remaining support delivered remotely, subject to agreement.\nThe scope and requirements described in this notice are indicative and may be refined following preliminary market engagement." } ], "items": [ { "id": "1", "additionalClassifications": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": [ { "scheme": "CPV", "id": "85149000", "description": "Pharmacy services" } ] } ], "relatedLot": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "1" } ] } ], "value": { "amountGross": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": 259200 } ], "amount": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": 216000 } ], "currency": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "GBP" } ] }, "mainProcurementCategory": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "services" } ], "aboveThreshold": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": true } ], "lots": [ { "id": "1", "suitability": { "sme": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": true } ], "vcse": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": true } ] }, "contractPeriod": { "startDate": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "2027-03-31T00:00:00+01:00" } ], "endDate": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "2030-03-31T23:59:59+01:00" } ], "maxExtentDate": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "2032-03-31T23:59:59+01:00" } ] }, "hasRenewal": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": true } ], "status": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "planning" } ] } ], "communication": { "futureNoticeDate": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "2026-12-04T23:59:59Z" } ] }, "status": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "planning" } ] }, "language": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": "en" } ], "extensions": [ { "releaseID": "094795-2026", "releaseDate": "2026-10-07T14:21:57+01:00", "releaseTag": [ "planning" ], "value": [ "https://standard.open-contracting.org/profiles/eu/latest/en/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_amendment_rationale_classifications_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_budget_breakdown_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_contract_completion_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_documentation_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_pagination_extension/master/extension.json", "https://raw.githubusercontent.com/open-contracting-extensions/ocds_suitability_extension/master/extension.json", "https://raw.githubusercontent.com/portaledcahn/ocds_Links_extension/main/extension.json", "https://raw.githubusercontent.com/cabinetoffice/ocds_uk_extension/main/extension.json" ] } ] } } ] }